Vaccine Compensation Awarded to Ashleigh Ellis for Alleged SIRVA Injury

Ashleigh Ellis, a petitioner from the United States, filed a claim under the National Vaccine Injury Compensation Program in January 2021, alleging that she suffered a shoulder injury related to vaccine administration (SIRVA) after receiving an influenza vaccine on October 17, 2020. The case, No. 21-620V, was heard by Chief Special Master Corcoran, who, following a joint stipulation between the parties, awarded Ellis a lump sum of $30,000. The stipulation, filed on June 17, 2025, acknowledged that Ellis had sustained a SIRVA injury and that the flu vaccine was the cause of her alleged injury.

Key Takeaways:

• The case, No. 21-620V, was filed under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10, et seq.
• Ashleigh Ellis alleged that she suffered a SIRVA injury following the administration of an influenza vaccine on October 17, 2020.
• The parties jointly stipulated that Ellis had sustained a SIRVA injury and that the flu vaccine was the cause of her alleged injury.
• Chief Special Master Corcoran awarded Ellis a lump sum of $30,000, to be paid through an ACH deposit to her counsel's IOLTA account for prompt disbursement to Ellis.
• The stipulation specifies that the $30,000 award represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).
• The parties agreed that the settlement and stipulation express a full and complete negotiated settlement of liability and damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended.

Statistics:

• Date of vaccination: October 17, 2020
• Date of stipulation: June 17, 2025
• Amount awarded: $30,000
• Duration of alleged injury: Over six months
• Type of injury: SIRVA (shoulder injury related to vaccine administration)

Sources:

• Vaccine Rule 18(b)
• 42 U.S.C. § 300aa-10, et seq. (National Vaccine Injury Compensation Program)
• Case 1:21-vv-00620-UNJ Document 59 Filed 07/17/25 Page 1 of 7